What's the buzz

Seaweed extract may cure lymphoma

A new research has shown that seaweed extract can help treat lymphoma, a cancer of the immune system.
It is classified into Hodgkin’s and non-Hodgkin’s types, which are then further classified into B-cell and T-cell groups.
“Some forms of B-cell lymphoma are especially resistant to standard treatment and thus new therapies are needed. In this study, we looked at a new treatment strategy using novel active compounds derived from a natural source — seaweed,” said Mohammad Irhimeh, Hashemite University, Jordan.
Seaweeds containing fucoidan, a sulfated polysaccharide similar to heparin in chemical structure, have been reported to have anti-tumour activity in mice and some cell lines.
For the study, Irhimeh and colleagues at the University of California, Berkeley, and Royal Hobart Hospital in Australia treated lymphoma cell lines with a commercially available seaweed extract.

Kidney donation doesn’t shorten donor’s life
Donating a kidney does not appear to significantly increase long-term risk of death, says a new research.
An examination of results for live kidney donors in the US over a 15-year period showed they had similar long-term survival rates as their healthy counterparts who had not donated a kidney.
The authors say: “Although many healthy adults are eager and willing to accept the risk of donor nephrectomy (surgical removal of a kidney) to help their loved ones, the responsibility lies within the medical community to quantify these risks as best as possible and to make this information available to those considering donation.”
Dorry L Segev of the Johns Hopkins University School of Medicine, Baltimore, and colleagues analysed the outcomes of live kidney donors (80,347) in the US between April 1, 1994, and March 31, 2009, who were drawn from a mandated national registry. Median follow-up was 6.3 years. A matched group was drawn from 9,364 participants of the third National Health and Nutrition Examination Survey (NHANES III).

New drug to slash cholesterol levels
Researchers from Swedish medical university Karolinska Institutet have found that a thyroid-hormone-like substance that works specifically on the liver reduces blood cholesterol with no serious side effects.
High cholesterol levels in the blood are primarily treated with a group of drugs called statins, but they are not always sufficiently effective and higher doses commonly cause adverse reactions. A clinical trial showed that a novel drug substance called eprotirome can reduce blood cholesterol effectively in patients who have already received statins.
Patients who were given supplementary medication with eprotirome demonstrated levels of harmful blood fats that were up to 30 per lower than those of patients who received a placebo supplementary treatment.

DH Newsletter Privacy Policy Get the top news in your inbox
Comments (+)